Secondary Hemophagocytic Lymphohistiocytosis, also known as acquired hemophagocytic lymphohistiocytosis, is related to hemophagocytic lymphohistiocytosis, familial, 1 and macrophage activation syndrome. The drugs Rituximab and Immunologic Factors have been mentioned in the context of this disorder. Affiliated tissues include liver and bone marrow.